Business
CTT Pursues Expansion Into New Industry Verticals and the United States with Business Development Appointments
CTT Pursues Expansion Into New Industry Verticals and the United States with Business Development Appointments.
About this update from Ctt Pharmaceutical Holdings, Inc.
[{"type":"text","content":"\n\n\n\nCTT Pursues Expansion Into New Industry Verticals and the United States with Business Development Appointments\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\nCTT Pursues Expansion Into New Industry Verticals and the United States with Business Development Appointments\nCanada NewsWire\nHAMILTON, ON, Sept. 1, 2020\n\n\n\nFocus expands to include nutraceutical and pharmaceutical sectors\nNew aggressive business development strategy\n HAMILTON, ON, Sept. 1, 2020 /CNW/ - CTT Pharmaceutical Holdings, Inc., (the \"Company\" or \"CTT\") (OTC: CTTH), an innovative life sciences company with a portfolio of IP in novel drug delivery systems, today announced that the Company is pivoting to a more aggressive business development model targeting new industry verticals and geographic jurisdictions. \nTo this end, the Company has strengthened its team with the appointment of Mr. Ryan Khouri and Dr. Greg Fedorcik as Director of Nutraceuticals and Director of Pharmaceuticals, respectively. Both Mr. Khouri and Dr Fedorcik will report to Marc Lakmaaker. Mr. Lakmaaker, previously appointed as special advisor to the Company, will take on additional responsibility as SVP Commercial Development at CTT. \nMr. Lakmaaker, a chemical engineer and former Aurora Cannabis executive, has been active in the cannabis sector for over 5 years in a variety of roles. He brings a solid track record in business development, including leading a sales team in the specialty chemicals sector. Mr. Lakmaaker founded Clearview Capital Consult, a strategy, IR and communications advisory in 2019, and has since helped various companies in the sector with a variety of corporate initiatives, such as strategic development, turnarounds, commercialization, capitalization and communications. \nMr. Lakmaaker commented, \"These appointments are an important first step in our pivot to a more aggressive commercial strategy and our entrance into the U.S. To date the Company's focus has been on commercialization within the cannabis industry, which was successfully achieved in lat...